- Temozolomide Drives Ferroptosis via a DMT1-Dependent Pathway in Glioblastoma Cells
-
Song Q, Peng S, Sun Z, Heng X, Zhu X
- KMID: 2519363
- Yonsei Med J.
- 2021 Sep;62(9):843-849.
- doi: 10.3349/ymj.2021.62.9.843
Purpose: Temozolomide is used in first-line treatment for glioblastoma. However, chemoresistance to temozolomide is common in glioma patients. In addition, mechanisms for the anti-tumor effects of temozolomide are largely unknown.... -
- CITED
-
- Close
- SHARE
-
- Close
